119th Congress
H.Res. 1079
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
- Introduced
- In committee
- Agreed to
- Sponsor
- Josh Gottheimer(D-NJ)
- Introduced
- Feb 25, 2026
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (1)
Original cosponsors (1)
- Don Bacon (R-NE)
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.
Roll-call votes
No recorded votes on this bill.
Actions
- Feb 25, 2026 · House
Referred to the House Committee on Energy and Commerce. - Feb 25, 2026
Submitted in House